2015 Therapeutic Proteins

Question 1

A new drug for the treatment of testicular cancer has been developed.  Based on the standard nomenclature for therapeutic antibodies, which of the following drugs would be most effective with the least likelihood of inducing a HAMA response? Answer

            A. Irgotzumab
            B. Irgotomab
            C. Irgoximab
            D. Irvirzumab
            E. Irviromab
            F. Irvirximab
            G. Irlimzumab
            H. Irlimomab
            I. Irlimximab

Email: Dr. Janet Fitzakerley | ©2015 University of Minnesota Medical School Duluth | Last modified: 27-apr-15 1:11 PM